Recurrent Mantle Cell Lymphoma Completed Phase Trials for Lithium carbonate (DB14509)

Also known as: Mantle Cell Lymphoma Recurrent

IndicationStatusPhase
DBCOND0028615 (Recurrent Mantle Cell Lymphoma)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00408681Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantSupportive Care